Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Evaluating the burden of amblyopia treatment from the parent and child's perspective.

Felius J, Chandler DL, Holmes JM, Chu RH, Cole SR, Hill M, Huang K, Kulp MT, Lazar EL, Matta NS, Melia M, Wallace DK; Pediatric Eye Disease Investigator Group.

J AAPOS. 2010 Oct;14(5):389-95. doi: 10.1016/j.jaapos.2010.07.009.

2.

Further validation of the Amblyopia Treatment Index parental questionnaire.

Holmes JM, Strauber S, Quinn GE, Cole SR, Felius J, Kulp M; Pediatric Eye Disease Investigator Group.

J AAPOS. 2008 Dec;12(6):581-4. doi: 10.1016/j.jaapos.2008.04.017. Epub 2008 Oct 30.

3.

Development and evaluation of a patching treatment questionnaire for Chinese amblyopic children.

Xu J, Lu Q, Huang Y, Chen Y, Chen J, Yu X.

Chin Med J (Engl). 2014;127(7):1261-5.

PMID:
24709177
4.

Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.

Repka MX, Kraker RT, Holmes JM, Summers AI, Glaser SR, Barnhardt CN, Tien DR; Pediatric Eye Disease Investigator Group.

JAMA Ophthalmol. 2014 Jul;132(7):799-805. doi: 10.1001/jamaophthalmol.2014.392.

5.

Impact of patching and atropine treatment on the child and family in the amblyopia treatment study.

Holmes JM, Beck RW, Kraker RT, Cole SR, Repka MX, Birch EE, Felius J, Christiansen SP, Coats DK, Kulp MT; Pediatric Eye Disease Investigator Group.

Arch Ophthalmol. 2003 Nov;121(11):1625-32.

PMID:
14609923
6.

Psychosocial distress of part-time occlusion in children with intermittent exotropia.

Kim US, Park S, Yoo HJ, Hwang JM.

Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):315-9. doi: 10.1007/s00417-012-2099-0. Epub 2012 Jul 11.

PMID:
22782302
7.

The Amblyopia Treatment Index.

Cole SR, Beck RW, Moke PS, Celano MP, Drews CD, Repka MX, Holmes JM, Birch EE, Kraker RT, Kip KE; Pediatric Eye Disease Investigator Group.

J AAPOS. 2001 Aug;5(4):250-4.

PMID:
11507585
8.

Treatment options for dense amblyopia in uncooperative children.

Arnold RW, Lichtenstein SJ.

J Pediatr Ophthalmol Strabismus. 2010 May-Jun;47(3):134-8. doi: 10.3928/01913913-20100505-01. No abstract available.

PMID:
20506995
9.

Treatment of severe amblyopia with weekend atropine: results from 2 randomized clinical trials.

Repka MX, Kraker RT, Beck RW, Birch E, Cotter SA, Holmes JM, Hertle RW, Hoover DL, Klimek DL, Marsh-Tootle W, Scheiman MM, Suh DW, Weakley DR; Pediatric Eye Disease Investigator Group.

J AAPOS. 2009 Jun;13(3):258-63. doi: 10.1016/j.jaapos.2009.03.002.

10.

A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children.

Pediatric Eye Disease Investigator Group.

Arch Ophthalmol. 2002 Mar;120(3):268-78.

PMID:
11879129
11.

A randomized trial of atropine regimens for treatment of moderate amblyopia in children.

Repka MX, Cotter SA, Beck RW, Kraker RT, Birch EE, Everett DF, Hertle RW, Holmes JM, Quinn GE, Sala NA, Scheiman MM, Stager DR Sr, Wallace DK; Pediatric Eye Disease Investigator Group.

Ophthalmology. 2004 Nov;111(11):2076-85.

PMID:
15522375
12.

The effect of media press coverage on parental preferences in amblyopia treatment.

Golden RP, Olitsky SE.

J AAPOS. 2005 Jun;9(3):212-5.

PMID:
15956939
13.

A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors.

Pediatric Eye Disease Investigator Group.

Ophthalmology. 2003 Aug;110(8):1632-7; discussion 1637-8.

PMID:
12917184
14.

The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study.

Pediatric Eye Disease Investigator Group.

Am J Ophthalmol. 2003 Oct;136(4):630-9.

PMID:
14516802
15.

Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children.

Searle A, Norman P, Harrad R, Vedhara K.

Eye (Lond). 2002 Mar;16(2):150-5.

16.

Randomized trial of treatment of amblyopia in children aged 7 to 17 years.

Scheiman MM, Hertle RW, Beck RW, Edwards AR, Birch E, Cotter SA, Crouch ER Jr, Cruz OA, Davitt BV, Donahue S, Holmes JM, Lyon DW, Repka MX, Sala NA, Silbert DI, Suh DW, Tamkins SM; Pediatric Eye Disease Investigator Group.

Arch Ophthalmol. 2005 Apr;123(4):437-47.

PMID:
15824215
17.

Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children.

Repka MX, Wallace DK, Beck RW, Kraker RT, Birch EE, Cotter SA, Donahue S, Everett DF, Hertle RW, Holmes JM, Quinn GE, Scheiman MM, Weakley DR; Pediatric Eye Disease Investigator Group.

Arch Ophthalmol. 2005 Feb;123(2):149-57.

PMID:
15710809
18.

Compliance and patching and atropine amblyopia treatments.

Wang J.

Vision Res. 2015 Sep;114:31-40. doi: 10.1016/j.visres.2015.02.012. Epub 2015 Mar 2. Review.

19.

Amblyopia therapy: an update.

Stewart CE, Moseley MJ, Fielder AR.

Strabismus. 2011 Sep;19(3):91-8. doi: 10.3109/09273972.2011.600421. Review.

PMID:
21870912
20.

Identification and treatment of amblyopia.

Bradfield YS.

Am Fam Physician. 2013 Mar 1;87(5):348-52. Erratum in: Am Fam Physician. 2013 Aug 1;88(3):159.

Supplemental Content

Support Center